3-((4-(1-((1-(4-((3R)-2,6-DIOXO-3-PIPERIDINYL)-3,5-DIFLUOROPHENYL)-3-AZETIDINYL)METHYL)-4-PIPERIDINYL)PHENYL)AMINO)-5-((3R)-3-(3-METHYL-2-OXO-1-IMIDAZOLIDINYL)-1-PIPERIDINYL)-2-PYRAZINECARBOXAMIDE
UNII L9BQN86ES2
Substance Identification & Data
This profile provides standardized clinical and technical data for 3-((4-(1-((1-(4-((3r)-2,6-dioxo-3-piperidinyl)-3,5-difluorophenyl)-3-azetidinyl)methyl)-4-piperidinyl)phenyl)amino)-5-((3r)-3-(3-methyl-2-oxo-1-imidazolidinyl)-1-piperidinyl)-2-pyrazinecarboxamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) L9BQN86ES2.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3096712-46-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C40H48F2N10O4 LDUBXDCQGXQRMF-PQHLKRTFSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 3-((4-(1-((1-(4-((3r)-2,6-dioxo-3-piperidinyl)-3,5-difluorophenyl)-3-azetidinyl)methyl)-4-piperidinyl)phenyl)amino)-5-((3r)-3-(3-methyl-2-oxo-1-imidazolidinyl)-1-piperidinyl)-2-pyrazinecarboxamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.